一种预先组织用于核糖体结合的抗生素克服了抗菌性
Kelvin J Y Wu1, Ben I C Tresco1, Antonio Ramkissoon1
1Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
概括
一种新型抗生素克雷索米辛 (CRM) 有效地对抗耐药细菌. 它的独特结构使其能够与细菌核糖体结合,即使经过耐药性酶的修改,也为抗菌药物耐药性提供了潜在的解决方案.
科学领域:
- 医学化学
- 微生物学
- 结构生物学
背景情况:
- 现代抗生素对不断发展的抗药性细菌越来越无效.
- 迫切需要新型抗菌剂来应对抗菌素耐药性日益严重的威胁.
- 当细菌发展出抗性机制时,如核糖体RNA修饰时,现有的抗生素会失败.
研究的目的:
- 报告一种新型跨桥式宏观循环抗生素 - - 克雷索米辛 (CRM) 的设计,合成和评估.
- 研究CRM对广泛细菌的有效性,包括多种耐药菌株.
- 阐明CRM作用机制的结构基础及其克服阻力的能力.
主要方法:
- 化学合成和微生物学的评估.
- 使用密度函数理论计算和X射线晶体学 (溶液状态,固态,核糖体结合) 确定CRM的结构.
- 用野生型和改性细菌核糖体 (Cfr和Erm甲基酶) 分析CRM核糖体复合体.
主要成果:
- 克雷索米辛 (CRM) 在体外和体内表现出对格拉姆阳性和格拉姆阴性细菌的有效性,包括耐药的黄金葡萄球菌,大肠杆菌和伪菌菌.
- 结构研究表明,CRM对核糖体结合具有高度预先组织,在不同状态下具有相同的宏观循环子单元对齐.
- 通过X射线结晶学显示,CRM维持了由Cfr和Erm甲基酶修饰的核糖体的结合,这表明它成功适应了抗性机制.
结论:
- 克雷索米辛 (CRM) 是一种有前途的新型抗生素,能够克服多种抗菌性机制.
- 在其他抗生素失效的情况下,CRM的预先组织结构和可适应的结合模式使其能够有效地向细菌核糖体.
- 这项研究为开发下一代抗生素来对抗耐药性感染提供了基础.
相关概念视频
Antibiotic Selection
53.5K
Overview
53.5K
Types of RNA
63.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.7K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Ribosome Profiling
3.5K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.5K
Antimicrobial Proteins
990
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
990
Riboswitches
8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K


